http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 10 Jun 2026 16:05:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUCELL+CORP+DE++++++++For%3A+Jun+04/26629843.html si-local-file:///var/storage/secattach/20260610/26629843.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUCELL+CORP+DE++++++++For%3A+Jun+04/26629843.html Wed, 10 Jun 2026 16:05:00 -0400 ICCC O.00001157 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUCELL+CORP+DE++++++++For%3A+Jun+04/26629843.html si-local-file:///var/storage/secattach/20260610/26629843.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUCELL+CORP+DE++++++++For%3A+Jun+04/26629843.html Wed, 10 Jun 2026 16:05:00 -0400 ICCC O.00001157 http://www.streetinsider.com/Earnings/Immucell+Corp+%28ICCC%29+Reports+Q1+EPS+of+%240.21/26495395.html <p>Immucell Corp (NASDAQ: ICCC) reported Q1 EPS of $0.21. Revenue for the quarter came in at $10.36 million, versus $0 reported last year.</p><p>For earnings history and earnings-related data on Immucell Corp (ICCC) <a href="http://www.streetinsider.com/ec_earnings.php?q=ICCC">click here</a>.</p> http://www.streetinsider.com/Earnings/Immucell+Corp+%28ICCC%29+Reports+Q1+EPS+of+%240.21/26495395.html Thu, 14 May 2026 16:21:06 -0400 ICCC http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUCELL+CORP+DE++++++++For%3A+May+14/26494875.html si-local-file:///var/storage/secattach/20260514/26494875.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUCELL+CORP+DE++++++++For%3A+May+14/26494875.html Thu, 14 May 2026 16:09:00 -0400 ICCC O.00001157 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUCELL+CORP+DE++++++++For%3A+May+14/26494875.html si-local-file:///var/storage/secattach/20260514/26494875.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUCELL+CORP+DE++++++++For%3A+May+14/26494875.html Thu, 14 May 2026 16:09:00 -0400 ICCC O.00001157 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++IMMUCELL+CORP+DE++++++++For%3A+Mar+31/26494804.html si-local-file:///var/storage/secattach/20260514/26494804.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++IMMUCELL+CORP+DE++++++++For%3A+Mar+31/26494804.html Thu, 14 May 2026 16:08:00 -0400 ICCC O.00001157 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++IMMUCELL+CORP+DE++++++++For%3A+Mar+31/26494804.html si-local-file:///var/storage/secattach/20260514/26494804.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++IMMUCELL+CORP+DE++++++++For%3A+Mar+31/26494804.html Thu, 14 May 2026 16:08:00 -0400 ICCC O.00001157 http://www.streetinsider.com/Press+Releases/ImmuCell+Announces+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26494603.html <p>PORTLAND, Maine, May 14, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health and productivity, today announced its unaudited financial results for the quarter ended March 31, 2026.</p> <p><strong>Management’s Discussion:</strong></p> <p>“Today we are reporting net income of $1.9 million for the first quarter of 2026, which is an increase of $0.5 million compared to the first quarter of 2025,” commented Timothy C. Fiori, Chief Financial Officer of ImmuCell. “These results were driven by 28.4% growth in product sales http://www.streetinsider.com/Press+Releases/ImmuCell+Announces+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26494603.html Thu, 14 May 2026 16:05:00 -0400 ICCC O.00001157 http://www.streetinsider.com/Press+Releases/ImmuCell+Announces+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26494603.html <p>PORTLAND, Maine, May 14, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health and productivity, today announced its unaudited financial results for the quarter ended March 31, 2026.</p> <p><strong>Management’s Discussion:</strong></p> <p>“Today we are reporting net income of $1.9 million for the first quarter of 2026, which is an increase of $0.5 million compared to the first quarter of 2025,” commented Timothy C. Fiori, Chief Financial Officer of ImmuCell. “These results were driven by 28.4% growth in product sales http://www.streetinsider.com/Press+Releases/ImmuCell+Announces+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26494603.html Thu, 14 May 2026 16:05:00 -0400 ICCC O.00001157 http://www.streetinsider.com/Globe+Newswire/ImmuCell+Announces+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26494603.html <p>PORTLAND, Maine, May 14, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health and productivity, today announced its unaudited financial results for the quarter ended March 31, 2026.</p> <p><strong>Management’s Discussion:</strong></p> <p>“Today we are reporting net income of $1.9 million for the first quarter of 2026, which is an increase of $0.5 million compared to the first quarter of 2025,” commented Timothy C. Fiori, Chief Financial Officer of ImmuCell. “These results were driven by 28.4% growth in product sales http://www.streetinsider.com/Globe+Newswire/ImmuCell+Announces+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26494603.html Thu, 14 May 2026 16:05:00 -0400 ICCC O.00001157 http://www.streetinsider.com/Globe+Newswire/ImmuCell+Announces+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26494603.html <p>PORTLAND, Maine, May 14, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health and productivity, today announced its unaudited financial results for the quarter ended March 31, 2026.</p> <p><strong>Management’s Discussion:</strong></p> <p>“Today we are reporting net income of $1.9 million for the first quarter of 2026, which is an increase of $0.5 million compared to the first quarter of 2025,” commented Timothy C. Fiori, Chief Financial Officer of ImmuCell. “These results were driven by 28.4% growth in product sales http://www.streetinsider.com/Globe+Newswire/ImmuCell+Announces+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26494603.html Thu, 14 May 2026 16:05:00 -0400 ICCC O.00001157 http://www.streetinsider.com/SEC+Filings/Form++10-KA+++++IMMUCELL+CORP+DE++++++++For%3A+Dec+31/26485975.html si-local-file:///var/storage/secattach/20260513/26485975.html http://www.streetinsider.com/SEC+Filings/Form++10-KA+++++IMMUCELL+CORP+DE++++++++For%3A+Dec+31/26485975.html Wed, 13 May 2026 16:07:00 -0400 ICCC O.00001157 http://www.streetinsider.com/SEC+Filings/Form++10-KA+++++IMMUCELL+CORP+DE++++++++For%3A+Dec+31/26485975.html si-local-file:///var/storage/secattach/20260513/26485975.html http://www.streetinsider.com/SEC+Filings/Form++10-KA+++++IMMUCELL+CORP+DE++++++++For%3A+Dec+31/26485975.html Wed, 13 May 2026 16:07:00 -0400 ICCC O.00001157 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUCELL+CORP+DE++++++++For%3A+May+08/26462229.html si-local-file:///var/storage/secattach/20260508/26462229.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUCELL+CORP+DE++++++++For%3A+May+08/26462229.html Fri, 08 May 2026 17:00:00 -0400 ICCC O.00001157 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUCELL+CORP+DE++++++++For%3A+May+08/26462229.html si-local-file:///var/storage/secattach/20260508/26462229.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUCELL+CORP+DE++++++++For%3A+May+08/26462229.html Fri, 08 May 2026 17:00:00 -0400 ICCC O.00001157 http://www.streetinsider.com/Press+Releases/ImmuCell+to+Announce+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26452970.html <p>PORTLAND, Maine, May 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health and productivity, expects to report unaudited financial results for the quarter ended March 31, 2026 after the market closes on Thursday, May 14, 2026.</p> <p>The Company is planning to host a conference call on Friday, May 15, 2026, at 9:00 AM ET to review the unaudited financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 http://www.streetinsider.com/Press+Releases/ImmuCell+to+Announce+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26452970.html Thu, 07 May 2026 16:05:00 -0400 ICCC O.00001157 http://www.streetinsider.com/Press+Releases/ImmuCell+to+Announce+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26452970.html <p>PORTLAND, Maine, May 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health and productivity, expects to report unaudited financial results for the quarter ended March 31, 2026 after the market closes on Thursday, May 14, 2026.</p> <p>The Company is planning to host a conference call on Friday, May 15, 2026, at 9:00 AM ET to review the unaudited financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 http://www.streetinsider.com/Press+Releases/ImmuCell+to+Announce+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26452970.html Thu, 07 May 2026 16:05:00 -0400 ICCC O.00001157 http://www.streetinsider.com/Globe+Newswire/ImmuCell+to+Announce+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26452970.html <p>PORTLAND, Maine, May 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health and productivity, expects to report unaudited financial results for the quarter ended March 31, 2026 after the market closes on Thursday, May 14, 2026.</p> <p>The Company is planning to host a conference call on Friday, May 15, 2026, at 9:00 AM ET to review the unaudited financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 http://www.streetinsider.com/Globe+Newswire/ImmuCell+to+Announce+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26452970.html Thu, 07 May 2026 16:05:00 -0400 ICCC O.00001157 http://www.streetinsider.com/Globe+Newswire/ImmuCell+to+Announce+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26452970.html <p>PORTLAND, Maine, May 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health and productivity, expects to report unaudited financial results for the quarter ended March 31, 2026 after the market closes on Thursday, May 14, 2026.</p> <p>The Company is planning to host a conference call on Friday, May 15, 2026, at 9:00 AM ET to review the unaudited financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 http://www.streetinsider.com/Globe+Newswire/ImmuCell+to+Announce+Unaudited+Financial+Results+for+the+Quarter+Ended+March+31%2C+2026/26452970.html Thu, 07 May 2026 16:05:00 -0400 ICCC O.00001157 http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++IMMUCELL+CORP+DE++++++++For%3A+Jun+11/26362454.html si-local-file:///var/storage/secattach/20260424/26362454.html http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++IMMUCELL+CORP+DE++++++++For%3A+Jun+11/26362454.html Fri, 24 Apr 2026 08:00:00 -0400 ICCC O.00001157 http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++IMMUCELL+CORP+DE++++++++For%3A+Jun+11/26362454.html si-local-file:///var/storage/secattach/20260424/26362454.html http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++IMMUCELL+CORP+DE++++++++For%3A+Jun+11/26362454.html Fri, 24 Apr 2026 08:00:00 -0400 ICCC O.00001157 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++IMMUCELL+CORP+DE++++++++For%3A+Apr+15++Filed+by%3A+DiMarco+Anthony/26357523.html si-local-file:///var/storage/secattach/20260423/26357523.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++IMMUCELL+CORP+DE++++++++For%3A+Apr+15++Filed+by%3A+DiMarco+Anthony/26357523.html Thu, 23 Apr 2026 12:29:00 -0400 ICCC O.00001157 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++IMMUCELL+CORP+DE++++++++For%3A+Apr+15++Filed+by%3A+DiMarco+Anthony/26357523.html si-local-file:///var/storage/secattach/20260423/26357523.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++IMMUCELL+CORP+DE++++++++For%3A+Apr+15++Filed+by%3A+DiMarco+Anthony/26357523.html Thu, 23 Apr 2026 12:29:00 -0400 ICCC O.00001157 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++IMMUCELL+CORP+DE++++++++For%3A+Apr+15++Filed+by%3A+Guillemette+Gilles/26357498.html si-local-file:///var/storage/secattach/20260423/26357498.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++IMMUCELL+CORP+DE++++++++For%3A+Apr+15++Filed+by%3A+Guillemette+Gilles/26357498.html Thu, 23 Apr 2026 12:27:00 -0400 ICCC O.00001157 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++IMMUCELL+CORP+DE++++++++For%3A+Apr+15++Filed+by%3A+Guillemette+Gilles/26357498.html si-local-file:///var/storage/secattach/20260423/26357498.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++IMMUCELL+CORP+DE++++++++For%3A+Apr+15++Filed+by%3A+Guillemette+Gilles/26357498.html Thu, 23 Apr 2026 12:27:00 -0400 ICCC O.00001157